The German pharmaceutical excipient market is estimated to grow at a CAGR of 6.3% during the forecast period. The market growth is attributed to the presence of well-established pharmaceutical industry coupled with significant R&D investments in the country. The country is one of the major centers for drug R&D all across the globe. As per the European Federation of Pharmaceutical Industries and Associations, around $8.3 billion was invested in pharmaceutical in 2017 in drug R&D in the country. Moreover, the recent COVID-19 outbreak in the country and across the globe has increased the demand for drugs. This, in turn, has significantly increased the demand for pharmaceutical excipient and hence drives the market growth.
The German pharmaceutical excipient market is segmented on the basis of product and formulations. Based on the product, the market is segmented into solubilizers & surfactants/emulsifiers, polyols, carbohydrates, and specialty excipients. Solubilizers & Surfactants/Emulsifiers covered in the report include triglycerides, esters, and others. in addition, polyols include mannitol, sorbitol, and others. Carbohydrates including sucrose, dextrose, starch, and others are estimated to hold a prominent share in the market. Based on formulations, the market is segmented into oral formulations, topical formulations, parenteral formulations, and other formulations. Oral formulations held a remarkable share in the market.
Moreover, the German pharmaceutical excipients market report covers the analysis of various players operating in the market. Some of the players operating in the market include Merck KGaA, DFE Pharma, BASF SE, Roquette Freres SA, Meggle AG, and others. Owing to increasing competition in the market, the players in the market adopting various strategies such as merger and acquisition and partnership and collaboration that tend to fuel market growth in the near future.
Research Methodology
The market study of the German pharmaceutical excipients market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research has been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for pharmaceutical excipients manufacturers, suppliers, raw material suppliers, traders, third-party distributors, healthcare industry, pharmaceutical and biopharmaceutical manufacturers, government organizations, regulatory authorities, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products & services offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Germany Pharmaceutical Excipient Market by Product
4.1.1. Solubilizer & Surfactants/Emulsifier
4.1.2. Polyols
4.1.3. Carbohydrates
4.1.4. Specialty Excipients
4.2. Germany Pharmaceutical Excipient Market by Formulation Type
4.2.1. Oral Formulation
4.2.2. Topical Formulation
4.2.3. Parenteral Formulation
4.2.4. Other Formulations
5. Company Profiles
5.1. ABITEC Corp.
5.1.1. Overview
5.1.2. ABITEC Corp. in Pharmaceutical Excipient Landscape
5.1.3. Recent Developments
5.2. BASF SE
5.3. Colorcon, Inc.
5.4. DFE Pharma
5.5. JRS PHARMA
5.6. Lyomark Pharma
5.7. Lubrizol Corp.
5.8. Merck KGaA
5.9. Meggle AG
5.10. Roquette Freres SA
1. GERMANY PHARMACEUTICAL EXCIPIENT MARKET RESEARCH AND ANALYSIS BY PRODUCT 2018-2025 ($ MILLION)
2. GERMANY PHARMACEUTICAL EXCIPIENT MARKET RESEARCH AND ANALYSIS BY FORMULATION, 2018-2025 ($ MILLION)
1. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
2. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SHARE BY FORMULATIONS, 2018 VS 2025 (%)
3. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2025 ($ MILLION)